Rankings
▼
Calendar
COLL FY 2021 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
FY 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$277M
-10.7% YoY
Gross Profit
$151M
54.4% margin
Operating Income
$18M
6.4% margin
Net Income
$72M
25.8% margin
EPS (Diluted)
$1.86
Cash Flow
Operating Cash Flow
$104M
Free Cash Flow
$102M
Stock-Based Comp.
$24M
Balance Sheet
Total Assets
$692M
Total Liabilities
$489M
Stockholders' Equity
$203M
Cash & Equivalents
$186M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$277M
$310M
-10.7%
Gross Profit
$151M
$180M
-16.2%
Operating Income
$18M
$56M
-68.7%
Net Income
$72M
$27M
+167.3%
← Q4 2020
All Quarters
Q1 2021 →